KOBE UNIVERSITY
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1949-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.kobe-u.ac.jp
Clinical Trials
168
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (161 trials with phase data)• Click on a phase to view related trials
A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )
- Conditions
- Lipoatrophic Diabetes MellitusInsulin Resistance SyndromeInsulin Resistance - Type AInsulin Resistance - Type B
- Interventions
- First Posted Date
- 2020-01-09
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Kobe University
- Target Recruit Count
- 8
- Registration Number
- NCT04221152
- Locations
- 🇯🇵
Kobe University Hospital, Kobe, Hyogo, Japan
🇯🇵Tohoku University Hospita, Sendai, Miyagi, Japan
🇯🇵Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance
- Conditions
- Insulin Resistance - Type BInsulin Resistance SyndromeInsulin Resistance - Type ALipoatrophic Diabetes Mellitus
- Interventions
- First Posted Date
- 2019-07-12
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Kobe University
- Target Recruit Count
- 8
- Registration Number
- NCT04018365
- Locations
- 🇯🇵
Kobe University Hospital, Kobe, Hyogo, Japan
🇯🇵Tohoku University Hospital, Sendai, Miyagi, Japan
🇯🇵Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
Evaluation of Fractional Flow Reserve Calculated by Computed Tomography Coronary Angiography in Patients Undergoing TAVR
- Conditions
- Coronary Artery DiseaseAortic Valve Stenosis
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- Kobe University
- Target Recruit Count
- 25
- Registration Number
- NCT03665389
Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]
- Conditions
- Coronary Artery DiseaseAngina Pectoris
- Interventions
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- Kobe University
- Target Recruit Count
- 75
- Registration Number
- NCT03657758
- Locations
- 🇯🇵
Kobe University Graduate School of Medicine, Department of Cardiology, Kobe, Hyogo, Japan
The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography
- First Posted Date
- 2018-06-11
- Last Posted Date
- 2018-11-14
- Lead Sponsor
- Kobe University
- Target Recruit Count
- 24
- Registration Number
- NCT03552432
- Locations
- 🇯🇵
Kobe University Graduate School of Medicine, Department of Cardiology, Kobe, Hyogo, Japan
- Prev
- 1
- 2
- 3
- 4
- Next
News
Aspirin and Heparin Combination Significantly Improves Live Birth Rates in Women with Recurrent Pregnancy Loss
A Kobe University-led study reveals that low-dose aspirin or heparin treatment significantly increases live birth rates in women with recurrent pregnancy loss who test positive for specific self-targeting antibodies.